Results 271 to 280 of about 44,418 (298)
Some of the next articles are maybe not open access.
Nihon rinsho. Japanese journal of clinical medicine, 2015
SU drug promotes insulin secretion by acting on pancreatic β cell. The hypoglycemic effect is the most powerful among oral diabetic drugs with high cost-effectiveness. Particularly for the Japanese with type 2 diabetes caused by a decrease in insulin secretion as a main pathological condition, it was widely used until the present since 1957 and largely
openaire +1 more source
SU drug promotes insulin secretion by acting on pancreatic β cell. The hypoglycemic effect is the most powerful among oral diabetic drugs with high cost-effectiveness. Particularly for the Japanese with type 2 diabetes caused by a decrease in insulin secretion as a main pathological condition, it was widely used until the present since 1957 and largely
openaire +1 more source
Clinical pharmacology of sulfonylureas
Metabolism, 1987Sulfonylureas seem to have similar mechanisms of action, including an acceleration and increase of insulin secretion, an increase of the systemic availability of insulin, and probably indirectly, an increase of insulin action. Sulfonylureas may postpone the development of impaired glucose tolerance (IGT) to manifest non-insulin-dependent diabetes ...
openaire +2 more sources
Sulfonamide-Sulfonylurea Interaction
New England Journal of Medicine, 1972H S, Tucker, J I, Hirsch
openaire +2 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2012
Kazuto, Kobayashi, Hitoshi, Shimano
openaire +1 more source
Kazuto, Kobayashi, Hitoshi, Shimano
openaire +1 more source